Differential Impact of Resistance-Associated Mutations to Protease Inhibitors and Nonnucleoside Reverse Transcriptase Inhibitors on HIV-1 Replication Capacity

Lignende værker

• Impact of first-line protease inhibitors on predicted resistance to tipranavir in HIV-1-infected patients with virological failure
  af: Hsieh, Szu-Min, et al.
  Udgivet: (2009)
• Mechanisms of inhibition of HIV replication by nonnucleoside reverse transcriptase inhibitors
  af: Sluis-Cremer, Nicolas, et al.
  Udgivet: (2008)
• Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana
  af: Moyo, Sikhulile, et al.
  Udgivet: (2019)
• Future of nonnucleoside reverse transcriptase inhibitors
  af: Sluis-Cremer, Nicolas
  Udgivet: (2018)
• The M230L Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutation in HIV-1 Reverse Transcriptase Impairs Enzymatic Function and Viral Replicative Capacity
  af: Xu, Hong-Tao, et al.
  Udgivet: (2010)